HomeRenewable energy ›Piramal Pharma Shifts to Renewable Biomass Briquettes, Slashes Carbon Footprint

Piramal Pharma Shifts to Renewable Biomass Briquettes, Slashes Carbon Footprint

The strategic conversion at Piramal Pharma's Digwal facility will eliminate approximately 24,000 tonnes of carbon dioxide equivalent (tCO2e) GHG emissions annually, accounting for about 17 percent of the company's total emissions.

January 16, 2025. By Abha Rustagi

Piramal Pharma Limited has converted its coal-fired steam boiler at its API and intermediates manufacturing facility in Digwal, India, to operate on biomass briquettes, a renewable energy fuel source. 

It is a step toward Piramal's sustainability goal to reduce Scope 1 and 2 greenhouse gas (GHG) emissions by 42 percent by 2030. The strategic conversion at the Digwal facility will eliminate approximately 24,000 tonnes of carbon dioxide equivalent (tCO2e) GHG emissions annually, accounting for about 17 percent of the company's total emissions.

"The transition to biomass briquettes at our Digwal facility is a testament to our commitment to reducing our environmental footprint while driving innovation in sustainable manufacturing. As we align our goals with global climate action frameworks, we will continue to contribute to a more sustainable future for generations to come," said Nandini Piramal, Chairperson, Piramal Pharma Limited.

Adopting biomass briquettes is a key advancement in Piramal's sustainability journey. These briquettes are compacted blocks of biomass materials processed and compressed under high pressure. Biomass briquettes, made from agricultural waste, are a renewable fuel source that supports circular economy principles by recycling organic by-products, reducing waste, and promoting sustainability.

"By transitioning to biomass briquettes, we are significantly reducing our GHG emissions and setting new industry standards for responsible pharmaceutical manufacturing," said Peter DeYoung, Chief Executive Officer of Piramal Global Pharma. 

This initiative supports Piramal's global sustainability goals and demonstrates how pharmaceutical companies can implement effective climate action solutions while maintaining operational excellence.
Please share! Email Buffer Digg Facebook Google LinkedIn Pinterest Reddit Twitter
If you want to cooperate with us and would like to reuse some of our content,
please contact: contact@energetica-india.net.
 
 
Next events
 
 
Last interviews
 
Follow us